Delivery Order SPE2DB22D1002-SPE2DB25FKZB9

Award Date 3/7/25
Potential Completion Date 3/10/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,574.46 and a completion date of September 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $86,445.85 and a completion date of September 3, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,084.38 firm-fixed-price contract is for the delivery of M-M-R II vaccine vials, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $14,510.94 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.57 firm fixed-price contract is for the procurement of M-M-R II vaccine vials, with a period of performance through December 31, 2024. The contract is not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $1,537.14 and is a firm fixed-price arrangement. The period of performance runs through July 22, 2024. This award does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. The contract is part of a larger Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of M-M-R II vaccine vials, with a ceiling value of $18,380.13 and a period of performance through December 12, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of M-M-R II vaccine vials. The contract has a total ceiling value of $1,113.35 and runs through March 3, 2025. The contract is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide M-M-R II vaccine vials. The contract has a ceiling value of $15,371.40 and a period of performance through July 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,206.03, is for the delivery of M-M-R II vaccine vials. The contract has a ceiling value of $45,206.03 and a completion date of February 28, 2025. It is a firm-fixed-price contract type. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKZB9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide M-M-R II vaccine vials. The contract has a ceiling value of $11,077.80 and runs through March 10, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 6/6/25, 9:56 AM